# Surgical Science Sweden - Lääketieteen leikkaussimulaattoreita Ruotsista

**URL:** https://forum.inderes.com/t/surgical-science-sweden-laaketieteen-leikkaussimulaattoreita-ruotsista/20737
**Category:** Osakkeet
**Tags:** surgical-science-sweden, ruotsalaisosakkeet
**Created:** [Heinäkuu 27, 2021, 6.58am UTC](https://forum.inderes.com/t/surgical-science-sweden-laaketieteen-leikkaussimulaattoreita-ruotsista/20737 "2021-07-27T06:58:18Z")
**Posts on this page:** 1
**Showing post:** 46

<div class="post-metadata">

### Author: ![timontti](https://forum.inderes.com/user_avatar/forum.inderes.com/timontti/32/214447_2.png) [@timontti](https://forum.inderes.com/u/timontti)
#### Post date: [Marraskuu 26, 2025, 7.56am UTC](https://forum.inderes.com/t/surgical-science-sweden-laaketieteen-leikkaussimulaattoreita-ruotsista/20737/46 "2025-11-26T07:56:30Z")

</div>

> Pareto Securities expects a double-digit decline for surgical simulator company Surgical Science after customer Intuitive terminated its letter of intent to integrate the company’s simulation software into all da Vinci 5 (dV5) robotic systems.
> 
> According to Surgical Science, this will result in a negative impact on licensing revenue of SEK 60-90 million next year.
> 
> In light of this announcement, Pareto has revised down its licensing estimates by 20 percent, and lowered next year’s revenue and operating profit forecasts by 12 and 50 percent, respectively.
> 
> This leads to both a lowered recommendation to hold (buy) and a lower target price of SEK 75 (130).
> 
> “Although the share price has already been weak in recent weeks, we expect the share to decline by double digits today,” the research house writes.

> **[Surgical Science: A fateful day](https://www.redeye.se/research/1140608/surgical-science-a-fateful-day?utm_source=note&utm_medium=email&notificationId=e5dbf06a-6a8e-44d7-9013-6109c1b01215)**
>
> Redeye comments on Surgical Science dropping an absolute bomb of a press release. Contrary to prior assumptions, Surgical Science’s simulation will only feature in a minority of da Vinci 5 robots. In

> Growing licence sales have been key to our investment thesis, driving both top-line and margin expansion. As this announcement significantly affects our estimates, it also has a marked effect on our valuation. Specifically, we lower our base case from SEK174 to SEK118. Similarly, our valuation range drops from SEK66-311 to SEK45-189 per share. While the share is already rather depressed, we expect these latest news to elicit a significant negative reaction. We will contemplate further adjustments to our estimates and valuation after the company’s capital markets day.

Taas yksi mätisäkki tänä vuonna salkussa edellisten lisäksi 😃 On tämäkin eräänlainen vuosi. Noh RE Top Picks taisi lisätä tätä juuri viime viikon lopulla tms.

---

_[View the full topic](https://forum.inderes.com/t/surgical-science-sweden-laaketieteen-leikkaussimulaattoreita-ruotsista/20737)._